Original-Research: Nabaltec AG - von NuWays AG Einstufung von NuWays AG zu Nabaltec AG Unternehmen: Nabaltec AG ISIN: DE000A0KPPR7 Anlass der Studie: Update Empfehlung: Kaufen seit: 26.04.2024 Kursziel: EUR 25.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Final FY23 as expected, solid start into FY24 2023 figures inline with prelims.
26.04.2024 - 09:01:33Original-Research: Nabaltec AG (von NuWays AG): Kaufen
Original-Research: Nabaltec AG - von NuWays AG Einstufung von NuWays AG zu Nabaltec AG Unternehmen: Nabaltec AG ISIN: DE000A0KPPR7 Anlass der Studie: Update Empfehlung: Kaufen seit: 26.04.2024 Kursziel: EUR 25.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Final FY23 as expected, solid start into FY24 2023 figures inline with prelims. To recap: FY23 sales decreased by 8.5% yoy to EUR 200m, largely driven by the highly cyclical Specialty Alumina segment, which reported sales of EUR 57.8m (-18.5% yoy). On the contrary, Functional Fillers' sales decreased by only 3.9% to EUR 142.3m, as revenues from boehmite and gap fillers grew by 6.1% yoy to EUR 22.4m, whereas boehmite alone showed a 9% yoy sales decline. Positively, the FY EBIT margin stood at 9.2% (-4.2pp yoy), EUR 18.3m absolute EBIT. Despite the muted operational performance and a 14% increase of working capital, the company generated EUR 2m of FCF. Nabaltec also released solid Q1 prelims, which render the FY24 guidance sensible. Q1 sales decreased 5.3% yoy to EUR 54m, largely due to a tough comparable base (Q1 FY23 with 4% growth vs a 12% decline during the remainder of FY23). Compared to the average of the past three quarters, Q1 sales were up 14%. In fact, the EBIT margin slightly increased by 0.2pp yoy to 9.3% (absolute EBIT of EUR 5m). With this, the lower end of the FY24 EBIT margin guidance looks well in reach, if not conservative as it implies a margin of only 6.2% for the remainder of the year. This compares to our 8.2% margin estimate for the rest of FY24e (eNuW: 3.9% yoy sales growth). As a reminder, management expects to grow FY24 sales slightly with an EBIT margin of 7-9%. Growth is expected to be carried by a slight increase of boehmite volumes (+1kt yoy), further growing gap filler demand and improving utilization rates at its US plants, while the remainder of F.F. and S.A. should remain rather flat yoy. Boehmite retains plenty of potential. During the past two years, the boehmite sales contribution decreased from EUR 24.2m in FY21 to EUR 17.3m last year. The main reason behind this was a strong oversupply in China (lacklustre EV demand growth), the core market for EV battery production and a slower than initially expected ramp up of production capacities in Europe and the US. Yet, with demand for ceramic coating solutions expected to 4x until 2028, boehmite should return to growth; eNuW: from EUR 17m in FY23 to EUR 25m by FY25e (conservatively below market growth). In sum, Nabaltec is a cyclical company that has passed the demand trough with a solid balance sheet, several structural growth drivers for core products and upside from boehmite. Valuation seem to lag behind with shares trading on 9/7x EV/EBIT FY24/25e. We confirm our BUY rating with an unchanged EUR 25 PT based on FCFY 24e and keep Nabaltec in our NuWays Alpha List. Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/29535.pdf Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden www.nuways-ag.com/research. Kontakt für Rückfragen NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++ -------------------übermittelt durch die EQS Group AG.------------------- Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
